source
- STAT+: Top lawmaker takes aim at doctor lobby, linking AMA’s billing codes to fraud fightA top Republican is asking if the AMA's codes are helping to fuel health care fraud.STAT · 2mo ago↗ source
- STAT+: Johnson & Johnson advances IBD therapy, despite trial missA closely watched therapy developed by Johnson & Johnson failed to show a statistically meaningful improvement for IBD patients.STAT · 2mo ago↗ source
- STAT+: French regulator fines Novo and Lilly over weight loss ad campaignsFrance's medicines regulator has fined Novo Nordisk and Eli Lilly over their weight loss ad campaigns.STAT · 2mo ago↗ source